Case Report: Delayed-onset and recurrent infectious endophthalmitis after intravitreal dexamethasone implant. [PDF]
Front Med (Lausanne)Yang X, Li M, Zhu Y, Tao X, Cheng Y.
europepmc +1 more source
Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model. [PDF]
Mol PharmJohnson C +6 more
europepmc +1 more source
Five-Year Treatment Outcomes with 0.19 µg Fluocinolone Acetonide in Radiation-Induced Maculopathy. [PDF]
Ocul Oncol PatholZimmermann L +4 more
europepmc +1 more source
Vogt-Koyanagi-Harada Disease: A Case Report Through Poliosis and Inflammatory Relapses. [PDF]
CureusWang Z +4 more
europepmc +1 more source
Pentraxin-3 and Lipocalin-2 are decreased in patients with uveal effusion syndrome. [PDF]
Int OphthalmolHavertz C +6 more
europepmc +1 more source
Anterior Chamber Migration of Dexamethasone Implant in a Patient Implanted with Carlevale Sutureless Scleral Fixation Intraocular Lens: A Case Report. [PDF]
Case Rep OphthalmolSejournet L +3 more
europepmc +1 more source
Inflammatory mechanisms in diabetic retinopathy: pathogenic roles and therapeutic perspectives. [PDF]
Am J Transl ResQian HY, Wei XH, Huang JO.
europepmc +1 more source
Immediate versus delayed dexamethasone implantation during vitrectomy for diabetic macular edema with secondary epiretinal membrane: A retrospective comparative study. [PDF]
J Int Med ResChen J.
europepmc +1 more source
Toxoplasma gondii retinochoroiditis associated with Epstein-Barr virus-induced retinal necrosis in an immunocompetent patient. [PDF]
J Ophthalmic Inflamm InfectSaturno MC +4 more
europepmc +1 more source
Back of the Eye Drug Delivery: Advances, Challenges, and Emerging Opportunities for Transformative Therapies. [PDF]
J Ocul Pharmacol TherChauhan A, Kompella U.
europepmc +1 more source